The expression of SEMA3F was detected by immunohistochemistry in postoperative tissue samples from patients with recurrent and nonrecurrent CRC who received adjuvant chemotherapy and were followed up for six years. This evidence concerns the gene SEMA3F and colorectal carcinoma.